ARCHIVES

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

Survival Rates Same For Two Treatments For Eye Cancer: Radiation Or Removal

July 27, 2001

Waksal To Pay Back $800,000 In Profits From Stock Sales

March 14, 2003

White House Yet To Name NCAB, Cancer Panel Members

February 11, 2011

Sandra Swain Elected ASCO President for 2012

December 10, 2010

ACS Board Approves Special Donors Concept, Oks New Program or Cause And Prevention Research

February 23, 1979

Without Advisor’s Input, Healy Approves Protocol For Gene Therapy

January 15, 1993